News & Events Year None2019201820172016201520142013201220112009 02/14/19 REGENXBIO to Host RGX-314 Program Analyst and Investor Event with Leading Retina Specialists 01/31/19 REGENXBIO Receives Rare Pediatric Disease Designation for RGX-181 Gene Therapy for the Treatment of CLN2 Form of Batten Disease 01/04/19 REGENXBIO to Present at the 37th Annual J.P. Morgan Healthcare Conference 01/03/19 REGENXBIO Reports Continued Progress Across Programs in Year-End 2018 Corporate Update
